Palmu AA - Search Results

1

Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects.

Haveri A, Solastie A, Ekström N, Österlund P, Nohynek H, Nieminen T, Palmu AA, Melin M. Haveri A, et al. Among authors: palmu aa. Eur J Immunol. 2022 May;52(5):816-824. doi: 10.1002/eji.202149785. Epub 2022 Mar 25. Eur J Immunol. 2022. PMID: 35312186 Free PMC article.

2

Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis.

Simell B, Vuorela A, Ekström N, Palmu A, Reunanen A, Meri S, Käyhty H, Väkeväinen M. Simell B, et al. Vaccine. 2011 Feb 24;29(10):1929-34. doi: 10.1016/j.vaccine.2010.12.121. Epub 2011 Jan 12. Vaccine. 2011. PMID: 21236231

3

Concentration and high avidity of pneumococcal antibodies persist at least 4 years after immunization with pneumococcal conjugate vaccine in infancy.

Ekström N, Ahman H, Palmu A, Grönholm S, Kilpi T, Käyhty H; FinOM Study Group. Ekström N, et al. Clin Vaccine Immunol. 2013 Jul;20(7):1034-40. doi: 10.1128/CVI.00039-13. Epub 2013 May 8. Clin Vaccine Immunol. 2013. PMID: 23658394 Free PMC article. Clinical Trial.

4

Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.

Jokinen J, Rinta-Kokko H, Siira L, Palmu AA, Virtanen MJ, Nohynek H, Virolainen-Julkunen A, Toropainen M, Nuorti JP. Jokinen J, et al. Among authors: palmu aa. PLoS One. 2015 Mar 17;10(3):e0120290. doi: 10.1371/journal.pone.0120290. eCollection 2015. PLoS One. 2015. PMID: 25781031 Free PMC article.

5

Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.

Palmu AA, Kilpi TM, Rinta-Kokko H, Nohynek H, Toropainen M, Nuorti JP, Jokinen J. Palmu AA, et al. Pediatrics. 2015 Jul;136(1):e22-7. doi: 10.1542/peds.2015-0458. Epub 2015 Jun 15. Pediatrics. 2015. PMID: 26077477 Clinical Trial.

6

Kontio M, Palmu AA, Syrjänen RK, Lahdenkari M, Ruokokoski E, Davidkin I, Vaarala O, Melin M. Kontio M, et al. Among authors: palmu aa. J Infect Dis. 2016 Jun 15;213(12):2005-13. doi: 10.1093/infdis/jiw058. Epub 2016 Feb 9. J Infect Dis. 2016. PMID: 26908733

7

Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.

Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Kilpi TM, Jokinen J. Palmu AA, et al. PLoS One. 2017 Mar 1;12(3):e0172690. doi: 10.1371/journal.pone.0172690. eCollection 2017. PLoS One. 2017. PMID: 28249015 Free PMC article.

8

Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.

Rinta-Kokko H, Palmu AA, Auranen K, Nuorti JP, Toropainen M, Siira L, Virtanen MJ, Nohynek H, Jokinen J. Rinta-Kokko H, et al. Among authors: palmu aa. Vaccine. 2018 Apr 5;36(15):1934-1940. doi: 10.1016/j.vaccine.2018.03.001. Epub 2018 Mar 8. Vaccine. 2018. PMID: 29526371

9

A pneumococcal conjugate vaccination programme reduced clinically suspected invasive disease in unvaccinated children.

Palmu AA, Rinta-Kokko H, Nuorti JP, Nohynek H, Jokinen J. Palmu AA, et al. Acta Paediatr. 2018 Sep;107(9):1610-1615. doi: 10.1111/apa.14335. Epub 2018 Apr 19. Acta Paediatr. 2018. PMID: 29577411

10

Register-Based Ecologic Evaluation of Safety Signals Related to Pneumococcal Conjugate Vaccine in Children.

Artama M, Rinta-Kokko H, Nohynek H, Jokinen J, Palmu AA. Artama M, et al. Among authors: palmu aa. Curr Drug Saf. 2018;13(2):107-112. doi: 10.2174/1574886313666180406164151. Curr Drug Saf. 2018. PMID: 29623819 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters